Literature DB >> 31166070

Long-term cardiovascular outcome of Williams syndrome.

Seul Gi Cha1, Mi Kyung Song1, Sang Yun Lee1, Gi Beom Kim1, Jae Gun Kwak2, Woong Han Kim2, Eun Jung Bae1.   

Abstract

OBJECTIVE: Cardiovascular lesions are the leading cause of morbidity and mortality in patients with Williams syndrome. Recent studies have rebutted conventional reports about the natural course of cardiovascular anomalies in Williams syndrome.
DESIGN: Retrospective study.
SETTING: Single tertiary center. PATIENTS: Eighty patients with Williams syndrome followed up for more than 5 years.
INTERVENTIONS: Not applicable. OUTCOME MEASURES: Long-term outcome of cardiovascular lesions, peak velocity change in obstructive cardiovascular lesions over time, post-interventional courses of disease-specific intervention, and intervention-free survival of obstructive cardiovascular lesions.
RESULTS: The median follow-up duration was 11.0 (5.1-28.3) years. Among 80 patients, supravalvular aortic stenosis (87.5%) was the most common cardiovascular lesion, followed by branch pulmonary stenosis (53.8%), mitral valve prolapse (22.5%), and aortic arch hypoplasia/coarctation (5.0%). During the follow-up period, the peak flow velocity of supravalvular aortic stenosis did not change on peak Doppler echocardiography. Initially, severe supravalvular aortic stenosis was aggravated (P < .027). Conversely, the peak velocity of branch pulmonary stenosis decreased (from 3.08 to 1.65 m/s; P < .001) within age 3.2 (0.4-6.9) years. Even the group with severe branch PS improved over time. Twenty-two patients (27.5%) with Williams syndrome underwent disease-specific interventions without mortality, mostly for supravalvular aortic stenosis or mitral valve prolapse. No patient in the late-onset and initially mild supravalvular aortic stenosis group needed intervention and 37.5%, 48.4%, and 65.1% in initially moderate and severe supravalvular aortic stenosis groups needed intervention at age 5, 10, and 20 years, respectively. Unlike the conventional therapeutic concept, the intervention for branch pulmonary stenosis was almost unnecessary.
CONCLUSIONS: In Williams syndrome, initially severe supravalvular aortic stenosis worsened over time and most branch pulmonary stenoses, including those in the severe group, improved spontaneously. Most patients with branch pulmonary stenosis did not require disease-specific intervention. Surgical repairs for cardiovascular abnormalities in Williams syndrome showed favorable results.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  Williams syndrome; branch pulmonary stenosis; cardiovascular lesion; long-term outcome; supravalvular aortic stenosis

Mesh:

Year:  2019        PMID: 31166070     DOI: 10.1111/chd.12810

Source DB:  PubMed          Journal:  Congenit Heart Dis        ISSN: 1747-079X            Impact factor:   2.007


  7 in total

Review 1.  Emerging mechanisms of elastin transcriptional regulation.

Authors:  Sara S Procknow; Beth A Kozel
Journal:  Am J Physiol Cell Physiol       Date:  2022-07-11       Impact factor: 5.282

2.  Long-Term Cardiovascular Findings in Williams Syndrome: A Single Medical Center Experience in Taiwan.

Authors:  Chung-Lin Lee; Shan-Miao Lin; Ming-Ren Chen; Chih-Kuang Chuang; Yu-Min Syu; Huei-Ching Chiu; Ru-Yi Tu; Yun-Ting Lo; Ya-Hui Chang; Hsiang-Yu Lin; Shuan-Pei Lin
Journal:  J Pers Med       Date:  2022-05-18

3.  Mid-trimester isolated bilateral rocker bottom feet leading to prenatal diagnosis of 7q11.23 microdeletion: Williams syndrome.

Authors:  David M Sherer; Vicky Hsieh; Freeda Granderson; Hakeem Yusuf; Mudar Dalloul
Journal:  J Ultrasound       Date:  2022-01-10

4.  Atypical deletion of Williams-Beuren syndrome reveals the mechanism of neurodevelopmental disorders.

Authors:  Jianrong Zhou; Ying Zheng; Guiying Liang; Xiaoli Xu; Jian Liu; Shaoxian Chen; Tongkai Ge; Pengju Wen; Yong Zhang; Xiaoqing Liu; Jian Zhuang; Yueheng Wu; Jimei Chen
Journal:  BMC Med Genomics       Date:  2022-04-04       Impact factor: 3.063

Review 5.  Williams syndrome.

Authors:  Beth A Kozel; Boaz Barak; Chong Ae Kim; Carolyn B Mervis; Lucy R Osborne; Melanie Porter; Barbara R Pober
Journal:  Nat Rev Dis Primers       Date:  2021-06-17       Impact factor: 65.038

6.  Commentary: You will see them again-sooner or later.

Authors:  Karthik Ramakrishnan; Can Yerebakan
Journal:  JTCVS Tech       Date:  2020-02-20

7.  Mitral Valve Prolapse and Its Motley Crew-Syndromic Prevalence, Pathophysiology, and Progression of a Common Heart Condition.

Authors:  Jordan E Morningstar; Annah Nieman; Christina Wang; Tyler Beck; Andrew Harvey; Russell A Norris
Journal:  J Am Heart Assoc       Date:  2021-06-22       Impact factor: 5.501

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.